Intersect Capital’s Thermo Fisher Scientific TMO Stock Holding History

Intersect Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$582K	Buy	1,072 +291	+37%	+$160K	0.18%	120
2022 Q1	$461K	Sell	781 -49	-6%	-$28.1K	0.09%	209
2021 Q4	$554K	Buy	830 +150	+22%	+$93.7K	0.1%	182
2021 Q3	$389K	Buy	680 +109	+19%	+$59.8K	0.07%	230
2021 Q2	$288K	Buy	571 +126	+28%	+$59.5K	0.05%	266
2021 Q1	$203K	Sell	445 -22	-5%	-$10.5K	0.04%	317
2020 Q4	$218K	Buy	+467	New	+$219K	0.05%	263
2015 Q2	–	Sell	-633	Closed	-$80K	–	341
2015 Q1	$80K	Hold	633	–	–	0.06%	139
2014 Q4	$79K	Buy	+633	New	+$77K	0.07%	147

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Intersect Capital's TMO Position: Q2 2022 in Review

Intersect Capital increased its Thermo Fisher Scientific (TMO) stake by 37% in Q2 2022, buying an estimated $160K and bringing the position to 1,072 shares worth $582K. The position accounts for 0.18% of the portfolio, ranked #120.

Intersect Capital first reported a position in TMO in Q4 2014 and has held it in 9 quarters since. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Intersect Capital held 1,072 shares of Thermo Fisher Scientific worth $582K as of Q2 2022.
Intersect Capital bought 291 Thermo Fisher Scientific shares in Q2 2022, an estimated $160K.
Thermo Fisher Scientific made up 0.18% of Intersect Capital's portfolio in Q2 2022, its #120 holding.
Intersect Capital first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 9 quarters since.
2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.